NASDAQ
Esperion Therapeutics, Inc. (ESPR) has a current ratio of 0.56x as of Tuesday, May 26, 2026. This represents a 77.26% decrease compared to its 12-month average of 2.45x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.